مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

2,313
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

SEROPREVALENCE OF CMV, TOXO, HEPATITIS B&C IN AVESINA INFERTILITY CLINIC LAB ATTENDEES

Pages

  59-63

Keywords

CMVQ3

Abstract

 Background and objective: Pregnancy is an important period for both mother and fetus. Some infections such as CMV, TOXOPLASMOSIS, and HEPATITIS B&C can induce unwanted complication such as mortality, morbidity and fetal or congenital malformations. Screening programs before pregnancy have a great role in diminishing these problems.Materials and methods: In this retrospective study we studied all serologic results of patients attending to Avesina Infertility Clinic Lab during Mehr to Esfand 1383(2004-2005). Serologic results, age and sex of patient were analyzed by T and chi square tests. Results: 97.9% of women and 100% of men had CMV antibodies. The most CMV seroprevalence was seen in 14-19, 40-44 and 45-49 year old women. We found 2.7% CMV IgM positive results mostly in 35-39 year old women. In women 16.8% showed Toxo IgG positive mostly in 45-59 year old group and 2.4% showed Toxo IgM positive results mostly in 14-19 years old group. 21.1% of women and 26.8% of men had antibodies against HEPATITIS B with most positively over 50 years old patients. There was a significant relation between age and HBsAb seropositivity. We found HBsAg seropositivity in 2.4% of women and 3.1% in men. There was a significant relation between age and HBsAg seropositivity. 0.4% of men were HCV Antibody positive but none of women.Conclusion: Based on the results it seems that screening women before pregnancy for CMV and TOXOPLASMOSIS is highly valuable. Diagnosis and treatment of TOXOPLASMOSIS during early stages of pregnancy is important in reducing prenatal transmission and its complications. Screening pregnant women for HBsAg is valuable because available prophylactic attempts can reduce prenatal transmission rate from 25-30% to 2-5% which is obviously considerable.So we recommended theses screening should be added to primary health care programs for pregnant women to reduce congenital infections and their adverse outcomes.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    CHAMANI, L., ZERAATI, HOJAT, ASGARI, SOHEYLA, SHABESTARI, O., SOLTAN GHORAEI, HALEH, & HABIBZADEH SHOJAEI, A.. (2007). SEROPREVALENCE OF CMV, TOXO, HEPATITIS B&C IN AVESINA INFERTILITY CLINIC LAB ATTENDEES. IRANIAN JOURNAL OF INFECTIOUS DISEASES AND TROPICAL MEDICINE, 11(35), 59-63. SID. https://sid.ir/paper/52926/en

    Vancouver: Copy

    CHAMANI L., ZERAATI HOJAT, ASGARI SOHEYLA, SHABESTARI O., SOLTAN GHORAEI HALEH, HABIBZADEH SHOJAEI A.. SEROPREVALENCE OF CMV, TOXO, HEPATITIS B&C IN AVESINA INFERTILITY CLINIC LAB ATTENDEES. IRANIAN JOURNAL OF INFECTIOUS DISEASES AND TROPICAL MEDICINE[Internet]. 2007;11(35):59-63. Available from: https://sid.ir/paper/52926/en

    IEEE: Copy

    L. CHAMANI, HOJAT ZERAATI, SOHEYLA ASGARI, O. SHABESTARI, HALEH SOLTAN GHORAEI, and A. HABIBZADEH SHOJAEI, “SEROPREVALENCE OF CMV, TOXO, HEPATITIS B&C IN AVESINA INFERTILITY CLINIC LAB ATTENDEES,” IRANIAN JOURNAL OF INFECTIOUS DISEASES AND TROPICAL MEDICINE, vol. 11, no. 35, pp. 59–63, 2007, [Online]. Available: https://sid.ir/paper/52926/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top